HIMS

Hims & Hers Health Inc

Feb 24 • 04:00PM ET

15.46

-0.05 -0.32 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NYSE

Feb 24, 2:41 PMHims & Hers Health discloses SEC investigation into statements on compounded semaglutide and GLP-1 business relationships after February document-preservation notice

Peers: ELF LFMD PRGO TDOC GDRX AMWL DOCS CLOV RXRX TWST

| Held by: VTI VB IJH IWM VBK VXF XMMO IWO VTWO MDY

Scroll to Statements

Index	RUT	P/E	29.61	EPS (ttm)	0.52	Insider Own	9.20%	Shs Outstand	218.87M	Perf Week	-4.98%
Market Cap	3.52B	Forward P/E	22.31	EPS next Y	0.69	Insider Trans	-3.23%	Shs Float	206.71M	Perf Month	-47.81%
Enterprise Value	4.06B	PEG	0.72	EPS next Q	0.03	Inst Own	81.22%	Short Float	37.14%	Perf Quarter	-54.02%
Income	128.37M	P/S	1.50	EPS this Y	6.16%	Inst Trans	-7.62%	Short Ratio	3.65	Perf Half Y	-65.31%
Sales	2.35B	P/B	6.49	EPS next Y	27.99%	ROA	8.92%	Short Interest	76.76M	Perf YTD	-52.39%
Book/sh	2.38	P/C	6.09	EPS next 5Y	31.13%	ROE	25.23%	52W High	70.43 -78.05%	Perf Year	-69.87%
Cash/sh	2.54	P/FCF	61.30	EPS past 3/5Y	- -	ROIC	7.75%	52W Low	15.15 2.01%	Perf 3Y	58.24%
Dividend Est.	-	EV/EBITDA	23.06	Sales past 3/5Y	64.55% 73.63%	Gross Margin	60.86%	Volatility	8.01% 9.21%	Perf 5Y	-8.14%
Dividend TTM	-	EV/Sales	1.73	EPS Y/Y TTM	-1.56%	Oper. Margin	5.18%	ATR (14)	1.85	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.61	Sales Y/Y TTM	59.00%	Profit Margin	5.47%	RSI (14)	16.32	Recom	2.83
Dividend Gr. 3/5Y	- -	Current Ratio	1.90	EPS Q/Q	-17.39%	SMA20	-26.04%	Beta	2.56	Target Price	19.94
Payout	0.00%	Debt/Eq	2.07	Sales Q/Q	28.41%	SMA50	-45.67%	Rel Volume	3.00	Prev Close	15.51
Employees	2442	LT Debt/Eq	2.06	Earnings	Feb 23 AMC	SMA200	-65.40%	Avg Volume	21.05M	Price	15.46
IPO	Sep 13, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	100.50% -0.23%	Trades		Volume	63,268,544	Change	-0.32%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-24-26	Downgrade	BTIG Research	Buy → Neutral
Jan-12-26	Initiated	Evercore ISI	In-line	$33
Dec-09-25	Initiated	Barclays	Overweight	$48
Oct-21-25	Initiated	KeyBanc Capital Markets	Sector Weight
Jun-23-25	Downgrade	Needham	Buy → Hold
Jun-04-25	Reiterated	Needham	Buy	$61 → $65
Apr-29-25	Downgrade	TD Cowen	Buy → Hold	$30
Feb-18-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$42 → $60
Jan-10-25	Downgrade	Citigroup	Neutral → Sell	$24 → $25
Jan-07-25	Initiated	BTIG Research	Buy	$35
Dec-17-24	Initiated	Morgan Stanley	Overweight	$42
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy	$24
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral	$16 → $20
Apr-16-24	Downgrade	Jefferies	Buy → Hold	$17 → $15
Apr-10-24	Initiated	Canaccord Genuity	Buy	$20
Feb-28-24	Upgrade	Imperial Capital	In-line → Outperform	$16
Feb-26-24	Initiated	Leerink Partners	Market Perform	$10
Dec-07-23	Initiated	Imperial Capital	In-line	$9

Show Previous Ratings

Feb-24-26 08:41PM	Stocks to Watch Tuesday Recap: Workday, Home Depot, Paramount, FedEx (The Wall Street Journal)
04:35PM	These Stocks Are Todays Movers: AMD, Hims & Hers, Keysight, IBM, Kratos, Vir Biotechnology, Whirlpool, and More (Barrons.com)
03:21PM	Stocks to Watch Tuesday: Home Depot, Paramount, JP Morgan, FedEx (The Wall Street Journal)
02:14PM	Hims & Hers Stock Faces Heavy Sell-Off Amid SEC Probe Into GLP-1 Disclosures (GuruFocus.com)
12:15PM	Hims & Hers Stock Slips Despite Q4 Earnings Beat, Margins Contract (Zacks)
10:09AM	Loading…
10:09AM	Hims & Hers Stock Drops. Why Earnings Are Underwhelming Investors. (Barrons.com)
09:59AM	Stocks Rebound as Software Stocks Recover (Barchart)
09:55AM	Meta, AMD announce chip partnership, Novo Nordisk cuts US GLP-1 prices (Yahoo Finance Video)
09:39AM	Qualcomm, Booking Holdings upgraded: Wall Street's top analyst calls (The Fly)
09:24AM	Hims & Hers Stumbles at the Open as Regulatory Damage Hits 2026 Outlook Hard (24/7 Wall St.)
08:32AM	Hims & Hers Stock Stumbles - Cautions About Pressure Due To Super Bowl Ad, Change In Shipping Cadences (Benzinga)
07:55AM	Earnings live: Home Depot stock climbs after earnings beat, Hims & Hers slides, Constellation Energy rises (Yahoo Finance)
07:53AM	Stocks to Watch Tuesday: FedEx, Home Depot, Novo Nordisk (The Wall Street Journal)
06:40AM	Hims & Hers Snaps EPS Losing Streak but Shares Still in Free Fall (24/7 Wall St.)
06:29AM	Stock Index Futures Mixed With Focus on Trumps SOTU Address and U.S. Economic Data (Barchart)
06:22AM	Loading…
06:22AM	Hims & Hers Q4 EPS Beats; Soft 2026 Outlook (GuruFocus.com)
06:12AM	Hims Expands Globally, Guides Higher (GuruFocus.com)
06:04AM	Hims & Hers Falls on Soft Q1 Revenue Guidance (GuruFocus.com)
05:58AM	These Stocks Are Today's Movers: Hims & Hers, IBM, BWX, Kratos, Diamondback, Vir, Home Depot, and More (Barrons.com)
05:52AM	Keysight jumps after earnings, and other early market movers (MarketWatch)
12:00AM	Hims & Hers Health Inc (HIMS) Q4 2025 Earnings Call Highlights: Record Growth and Strategic ... (GuruFocus.com)
Feb-23-26 09:09PM	Hims & Hers Health Q4 Earnings Call Highlights (MarketBeat)
08:18PM	Hims & Hers Health, Novo Nordisk, PayPal, Uber And BWX Technologies: Why These 5 Stocks Are On Investors' Radars Today (Benzinga)
07:44PM	Hims & Hers' expansion plans - as well as its Super Bowl ad - have investors worried about profits (MarketWatch)
07:25PM	Hims & Hers Health, Inc. (HIMS) Surpasses Q4 Earnings Estimates (Zacks)
06:49PM	Hims & Hers Health Fourth-Quarter Sales Rise, Gives Soft First-Quarter Guidance (The Wall Street Journal)
05:33PM	Stocks to Watch Monday Recap: Diamondback, Netflix, Novo Nordisk, Lilly (The Wall Street Journal)
04:59PM	Earnings live: Hims & Hers stock slides, Domino's rises as investors await crucial update from Nvidia (Yahoo Finance)
04:58PM	Hims & Hers beats on Q4 earnings, shares down in line guidance (Investing.com)
04:50PM	Dow Jones Futures: Trump Tariffs Spark Stock Market Sell-Off; Apple, Nvidia, Tesla Are Key Movers (Investor's Business Daily)
04:31PM	Loading…
04:31PM	Hims & Hers Health Fourth-Quarter Profit Falls Despite Higher Revenue (The Wall Street Journal)
04:25PM	Hims & Hers Stock Falls. Why Earnings Are Underwhelming Investors. (Barrons.com)
04:24PM	Hims & Hers Health, Inc. (HIMS) Expands Global Footprint With Eucalyptus Acquisition (Insider Monkey)
04:23PM	Hims & Hers Health's (NYSE:HIMS) Q4 CY2025 Earnings Results: Revenue In Line With Expectations (StockStory)
04:05PM	Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
11:21AM	Hims & Hers to Report Q4 Earnings Amid Guidance Concerns (GuruFocus.com)
11:10AM	Market Awaits Factory Orders Data (Zacks)
10:36AM	NVIDIA Highlights This Week of Market Reportage (Zacks)
10:33AM	Nvidia, Joby, CoreWeave, Lucid and More Stocks with Earnings This Week (Benzinga)
09:08AM	Hims & Hers In Focus Before Q4 Earnings Release (Benzinga)
05:06AM	Stocks to Watch Monday: Domino's Pizza, Novo Nordisk, Eli Lilly, Delta (The Wall Street Journal)
03:56AM	Nvidia Earnings, Inflation Data, State of the Union Address: What to Watch This Week (The Wall Street Journal)
03:33AM	Nvidia, Home Depot Earnings; Inflation Data: What to Watch This Week (The Wall Street Journal)
Feb-22-26 05:03AM	GLP-1 wars: Wegovy maker challenges knock-off weight loss drug companies (USA TODAY)
Feb-21-26 10:07PM	What To Expect From Hims & Hers Health's (HIMS) Q4 Earnings (StockStory)
10:03AM	Hims & Hers in Free Fall: Why Analysts See Nearly 150% Upside (MarketBeat)
08:31AM	Super Micro Computer, Blue Owl, Hims & Hers And More: 5 Stocks Investors Couldn't Stop Buzzing About This Week (Benzinga)
Feb-20-26 05:30PM	Nvidia Earnings, PPI: What to Watch Next Week (The Wall Street Journal)
02:09PM	Geopolitical Tensions Resurface Amid Volatile Week (Schaeffer's Research)
11:51AM	Hims & Hers $1.2 Billion Global Leap: Can Eucalyptus Cure its GLP-1 Ills? (24/7 Wall St.)
10:55AM	Hims & Hers Accelerates AI Preventive Care and Platform Strategy (Zacks)
09:44AM	Grail Stock Tanks After Cancer-Screening Study (The Wall Street Journal)
06:07AM	The Weekly Closeout: New Balance hits record sales in 2025, Chinese Laundry acquired (Retail Dive)
Feb-19-26 05:06PM	Biotech Grail shares plunge after key trial fails to meet primary endpoint (Investing.com)
04:37PM	These Stocks Are Todays Movers: Walmart, Occidental, Klarna, Wayfair, Deere, Omnicom, EPAM, and More (Barrons.com)
02:55PM	Hims & Hers to Buy Australian Telehealth Provider Eucalyptus in $1.15 Billion Deal (Barrons.com)
01:11PM	Hims & Hers to Acquire Eucalyptus in Deal Valued Up to $1.15B (GuruFocus.com)
01:04PM	Hims & Hers to acquire Australian digital health firm Eucalyptus, expanding international footprint (Proactive)
12:32PM	Analyst Report: Hims & Hers Health, Inc. (Morningstar Research)
11:12AM	Can Platform Strength Support Hims & Hers Stock Before Q4 Earnings? (Zacks)
10:34AM	Hims & Hers Health Stock Resumes Climb on Acquisition News (Schaeffer's Research)
10:13AM	Hims & Hers Agrees To Buy Eucalyptus In $1.15 Bil Deal. Stock Rallies. (Investor's Business Daily)
08:50AM	Hims & Hers Health $1 Billion Eucalyptus Acquisition Fuels Global Expansion Dreams (Benzinga)
08:08AM	Hims & Hers is spending more than $1 billion in a push to expand globally (MarketWatch)
07:31AM	Hims & Hers to Acquire Eucalyptus in $1.15 Billion Deal (The Wall Street Journal)
07:25AM	Hims & Hers Stock Jumps on $1.15 Billion Deal to Acquire Australian Telehealth Provider (Barrons.com)
07:04AM	Hims & Hers Q4 Earnings Preview: What To Expect From Upcoming Report (GuruFocus.com)
06:00AM	Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform (Business Wire)
Feb-18-26 05:45PM	Hims & Hers Health, Inc. (HIMS) Stock Dips While Market Gains: Key Facts (Zacks)
01:16AM	Deutsche Bank Cite Near-Term Growth Concerns For Hims & Hers Health, Inc. (HIMS) Following GLP-1 Launch Reversal (Insider Monkey)
Feb-17-26 11:10AM	Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk (Investor's Business Daily)
Feb-16-26 11:19AM	Wall Street Sees 84% Upside in Hims & Hers (HIMS) Despite This Months 48% Selloff (24/7 Wall St.)
10:00AM	Analysts Estimate Hims & Hers Health, Inc. (HIMS) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-14-26 05:30AM	How Ozempic Brought a Napster Moment to Big Pharma (The Wall Street Journal)
Feb-13-26 03:32PM	Top 10 Most Shorted Stocks: CleanSpark, Hims & Hers And More (Benzinga)
02:08PM	Hims & Hers Falls Over 50% as Novo Files Obesity Lawsuit (GuruFocus.com)
06:21AM	Analysis-US could take action including fines against Hims after brief Wegovy copy launch (Reuters)
Feb-12-26 01:02PM	Novo Nordisk Plans Wegovy Vial Launch To Counter Eli Lilly, Target Broader Obesity Market (Benzinga) -5.33%
11:20AM	Mixed options sentiment in Hims and Hers Health with shares down 2.18% (TipRanks)
09:59AM	Hims & Hers Strengthens Integrated Personalized Digital Care Platform (Zacks)
04:23AM	Novo Nordisk CEO Sees Opportunity For 15 Million New Patients As Medicare Covers Obesity Drugs (Benzinga)
Feb-11-26 11:56AM	Telehealth stocks pressured as Amazon Pharmacy expands prescription delivery (Investing.com)
11:13AM	HIMS Dips 55.8% in 3 Months: Should You Still Hold the Stock or Sell? (Zacks)
08:59AM	Taking the new Wegovy pill every day is really complicated. Will patients stick with it? (MarketWatch)
06:46AM	Hims & Hers Halts Compounded Semaglutide Pill Offering After FDA's Crackdown Warning (Benzinga)
Feb-10-26 07:21PM	Analyst Report: Hims & Hers Health, Inc. (Morningstar Research) -10.81%
03:48PM	Taking the new Wegovy pill every day is really complicated. Will patients stick with it? (MarketWatch)
10:23AM	Novo Nordisk opens new front with patent suit over Hims Wegovy copies (Reuters Videos)
09:59AM	As Hims & Hers Gets Hit With Major Wegovy Loss, Should You Buy the Dip in Deeply Oversold HIMS Stock? (Barchart)
08:51AM	Hims & Hers says Novo Nordisk lawsuit blatant attack on millions of Americans (TipRanks)
07:11AM	Novo Nordisk Rallies 3.6% as Hims & Hers Pulls Compounded Semaglutide (Zacks)
03:02AM	Heard on the Street Monday Recap: Homebuilder Industry Strikes Back (The Wall Street Journal)
12:01AM	Novo Nordisk Launches Suit to Knock Out Hims & Hers Weight Loss Knockoffs (The Daily Upside)
12:01AM	Morgan Stanley Begins Coverage Of Bitcoin Miners As Wider Infrastructure Plays (The Daily Upside)
Feb-09-26 05:45PM	Hims & Hers Health, Inc. (HIMS) Stock Dips While Market Gains: Key Facts (Zacks) -16.03%
05:23PM	Hims & Hers stock plunges after weight loss pill pulled amid FDA scrutiny (CBS News Videos)
05:20PM	Stocks to Watch Monday Recap: Novo Nordisk, Hims & Hers, Apollo (The Wall Street Journal)
04:42PM	Stock Market Today: Dow Up As Oracle Soars; Cathie Wood Buys Buffett Stock Amid 145% Run (Live Coverage) (Investor's Business Daily)
04:34PM	Stocks Settle Higher on Strength in Tech (Barchart)
04:19PM	These Stocks Are Todays Movers: Kyndryl, Hims & Hers, Novo Nordisk, Oracle, Nvidia, AppLovin, and More (Barrons.com)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Okupe Oluyemi	Chief Financial Officer	Feb 03 '26	Option Exercise	5.01	5,262	26,363	96,879	Feb 04 04:13 PM
Okupe Oluyemi	Chief Financial Officer	Feb 03 '26	Sale	26.44	5,262	139,108	91,617	Feb 04 04:13 PM
Okupe Oluyemi	Chief Financial Officer	Jan 20 '26	Option Exercise	6.27	9,067	56,836	100,684	Jan 21 04:23 PM
Okupe Oluyemi	Chief Financial Officer	Jan 20 '26	Sale	30.34	9,067	275,114	91,617	Jan 21 04:23 PM
Oluyemi Okupe	Officer	Jan 20 '26	Proposed Sale	30.47	27,204	828,906		Jan 20 04:34 PM
Okupe Oluyemi	Chief Financial Officer	Jan 05 '26	Option Exercise	9.16	5,986	54,818	100,687	Jan 07 04:16 PM
Okupe Oluyemi	Chief Financial Officer	Jan 05 '26	Sale	33.79	9,070	306,453	91,617	Jan 07 04:16 PM
Okupe Oluyemi	Chief Financial Officer	Dec 22 '25	Sale	35.72	23,090	824,710	94,333	Dec 23 04:15 PM
Oluyemi Okupe	Officer	Dec 22 '25	Proposed Sale	35.05	32,160	1,127,208		Dec 22 05:00 PM
Chi Michael	Chief Operating Officer	Dec 17 '25	Sale	36.71	13,750	504,762	305,161	Dec 18 04:15 PM
Autor Deborah M.	Chief Policy Officer	Dec 17 '25	Sale	36.71	7,054	258,952	6,175	Dec 18 04:15 PM
Carroll Patrick Harrison	Chief Medical Officer	Dec 17 '25	Sale	36.71	10,021	367,871	169,940	Dec 18 04:15 PM
Becklund Irene	PAO	Dec 17 '25	Sale	36.71	8,411	308,768	2,126	Dec 18 04:15 PM
Carroll Patrick Harrison	Officer	Dec 17 '25	Proposed Sale	36.71	10,021	367,871		Dec 17 10:26 AM
Chi Michael	Officer	Dec 17 '25	Proposed Sale	36.71	13,750	504,762		Dec 17 10:14 AM
Becklund Irene	Officer	Dec 17 '25	Proposed Sale	36.71	8,411	308,768		Dec 17 09:50 AM
Autor Deborah M.	Officer	Dec 17 '25	Proposed Sale	36.71	7,054	258,952		Dec 17 09:42 AM
Perez Garcia Andrea G	Director	Dec 09 '25	Sale	39.17	2,500	97,925	80,166	Dec 10 04:35 PM
Perez Garcia Andrea G	Director	Dec 09 '25	Proposed Sale	39.17	2,500	97,925		Dec 09 10:07 AM
Boughton Soleil	Chief Legal Officer	Nov 24 '25	Sale	35.22	2,631	92,664	153,225	Nov 25 04:13 PM
Boughton Soleil	Officer	Nov 24 '25	Proposed Sale	35.11	2,631	92,374		Nov 24 10:03 AM
Okupe Oluyemi	Chief Financial Officer	Nov 17 '25	Option Exercise	7.15	23,187	165,817	93,419	Nov 19 04:31 PM
Okupe Oluyemi	Chief Financial Officer	Nov 17 '25	Sale	36.81	23,187	853,490	70,232	Nov 19 04:31 PM
Boughton Soleil	Chief Legal Officer	Nov 10 '25	Sale	42.53	2,637	112,152	155,856	Nov 12 08:02 PM
Boughton Soleil	Officer	Nov 10 '25	Proposed Sale	42.53	2,637	112,152		Nov 10 10:16 AM
Boughton Soleil	Chief Legal Officer	Oct 27 '25	Sale	50.10	2,637	132,114	158,493	Oct 28 04:23 PM
Boughton Soleil	Officer	Oct 27 '25	Proposed Sale	50.10	2,637	132,114		Oct 27 09:42 AM
Okupe Oluyemi	Chief Financial Officer	Oct 17 '25	Option Exercise	7.15	11,592	82,898	81,824	Oct 20 04:42 PM
Okupe Oluyemi	Chief Financial Officer	Oct 17 '25	Sale	57.13	11,592	662,222	70,232	Oct 20 04:42 PM
Dudum Andrew	Officer	Oct 16 '25	Proposed Sale	62.79	175,661	11,029,998		Oct 16 03:10 PM
Chi Michael	Chief Commercial Officer	Oct 10 '25	Option Exercise	6.82	900	6,138	292,339	Oct 14 04:17 PM
Chi Michael	Chief Commercial Officer	Oct 10 '25	Sale	58.25	900	52,425	291,439	Oct 14 04:17 PM
Boughton Soleil	Chief Legal Officer	Oct 13 '25	Sale	54.38	2,637	143,400	161,130	Oct 14 04:17 PM
Boughton Soleil	Officer	Oct 13 '25	Proposed Sale	54.38	2,637	143,400		Oct 14 06:47 AM
Chi Michael	Officer	Oct 10 '25	Proposed Sale	58.25	900	52,425		Oct 10 11:26 AM
Okupe Oluyemi	Chief Financial Officer	Oct 03 '25	Option Exercise	7.15	11,595	82,919	81,827	Oct 07 04:47 PM
Okupe Oluyemi	Chief Financial Officer	Oct 03 '25	Sale	57.72	11,595	669,232	70,232	Oct 07 04:47 PM
Chi Michael	Chief Commercial Officer	Oct 01 '25	Option Exercise	11.53	250	2,882	291,689	Oct 02 04:10 PM
Chi Michael	Chief Commercial Officer	Oct 01 '25	Sale	56.00	250	14,000	291,439	Oct 02 04:10 PM
Chi Michael	Officer	Oct 01 '25	Proposed Sale	56.00	250	14,000		Oct 01 11:34 AM
Okupe Oluyemi	Chief Financial Officer	Sep 29 '25	Option Exercise	5.01	49,832	249,658	155,232	Sep 30 04:33 PM
Okupe Oluyemi	Chief Financial Officer	Sep 29 '25	Sale	60.20	85,000	5,116,924	70,232	Sep 30 04:33 PM
Boughton Soleil	Chief Legal Officer	Sep 29 '25	Sale	58.79	2,637	155,029	163,767	Sep 30 04:33 PM
Boughton Soleil	Officer	Sep 29 '25	Proposed Sale	58.79	2,637	155,029		Sep 29 09:51 AM
Chi Michael	Chief Commercial Officer	Sep 24 '25	Option Exercise	5.01	2,100	10,521	293,539	Sep 25 06:06 PM
Chi Michael	Chief Commercial Officer	Sep 24 '25	Sale	56.52	2,100	118,692	291,439	Sep 25 06:06 PM
Okupe Oluyemi	Chief Financial Officer	Sep 22 '25	Sale	57.74	23,584	1,361,766	105,400	Sep 24 04:22 PM
Chi Michael	Officer	Sep 24 '25	Proposed Sale	56.52	2,100	118,692		Sep 24 11:02 AM
Oluyemi Okupe	Officer	Sep 22 '25	Proposed Sale	57.70	154,958	8,941,077		Sep 22 05:39 PM
Boughton Soleil	Chief Legal Officer	Sep 17 '25	Sale	50.50	2,637	133,168	166,404	Sep 19 04:28 PM
Carroll Patrick Harrison	Chief Medical Officer	Sep 17 '25	Sale	50.50	10,021	506,060	169,940	Sep 19 04:28 PM
Becklund Irene	PAO	Sep 17 '25	Sale	50.50	8,410	424,705	1,418	Sep 19 04:28 PM
Chi Michael	Chief Commercial Officer	Sep 17 '25	Sale	50.50	13,749	694,324	297,139	Sep 19 04:27 PM
Dudum Andrew	Chief Executive Officer	Sep 17 '25	Sale	50.57	65,110	3,292,906	95,315	Sep 19 04:27 PM
Chi Michael	Chief Commercial Officer	Sep 15 '25	Option Exercise	6.19	4,150	25,680	282,804	Sep 17 07:24 PM
Chi Michael	Chief Commercial Officer	Sep 15 '25	Sale	56.00	4,150	232,400	278,654	Sep 17 07:24 PM
Dudum Andrew	Chief Executive Officer	Sep 16 '25	Option Exercise	2.43	125,335	304,564	268,759	Sep 17 07:24 PM
Dudum Andrew	Chief Executive Officer	Sep 16 '25	Sale	53.48	128,127	6,852,300	160,425	Sep 17 07:24 PM
Dudum Andrew	Chief Executive Officer	Sep 16 '25	Sale	53.27	47,534	2,532,325	95,058	Sep 17 07:24 PM
Okupe Oluyemi	Chief Financial Officer	Sep 15 '25	Option Exercise	5.01	110,000	551,100	273,984	Sep 17 07:24 PM
Okupe Oluyemi	Chief Financial Officer	Sep 15 '25	Sale	55.35	145,000	8,026,076	128,984	Sep 17 07:24 PM
Dudum Andrew	Officer	Sep 17 '25	Proposed Sale	50.57	65,110	3,292,904		Sep 17 12:44 PM
Boughton Soleil	Officer	Sep 17 '25	Proposed Sale	50.50	2,637	133,168		Sep 17 11:15 AM
Carroll Patrick Harrison	Officer	Sep 17 '25	Proposed Sale	50.50	10,021	506,060		Sep 17 10:20 AM
Chi Michael	Officer	Sep 17 '25	Proposed Sale	50.50	13,749	694,324		Sep 17 10:07 AM
Becklund Irene	Officer	Sep 17 '25	Proposed Sale	50.50	8,410	424,705		Sep 17 09:50 AM
Dudum Andrew	Officer	Sep 16 '25	Proposed Sale	53.42	175,661	9,384,626		Sep 16 11:29 AM
Oluyemi Okupe	Officer	Sep 15 '25	Proposed Sale	53.96	145,000	7,824,200		Sep 15 06:35 PM
Chi Michael	Officer	Sep 15 '25	Proposed Sale	56.00	4,150	232,400		Sep 15 11:49 AM
Okupe Oluyemi	Chief Financial Officer	Aug 26 '25	Option Exercise	5.01	11,581	58,021	128,387	Aug 28 04:34 PM
Okupe Oluyemi	Chief Financial Officer	Aug 26 '25	Sale	43.69	11,581	505,968	116,806	Aug 28 04:34 PM
Boughton Soleil	Chief Legal Officer	Aug 25 '25	Sale	44.53	2,571	114,487	150,450	Aug 26 04:35 PM
Boughton Soleil	Officer	Aug 25 '25	Proposed Sale	44.53	2,571	114,487		Aug 25 09:46 AM
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Option Exercise	2.43	125,335	304,564	197,855	Aug 20 04:14 PM
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Sale	45.06	128,127	5,773,242	89,521	Aug 20 04:14 PM
Dudum Andrew	Chief Executive Officer	Aug 18 '25	Sale	45.05	47,534	2,141,492	142,592	Aug 20 04:14 PM
Dudum Andrew	Officer	Aug 18 '25	Proposed Sale	45.05	47,534	2,141,494		Aug 18 12:33 PM
Dudum Andrew	Officer	Aug 18 '25	Proposed Sale	45.22	128,127	5,793,903		Aug 18 10:22 AM
Okupe Oluyemi	Chief Financial Officer	Aug 13 '25	Option Exercise	5.01	11,581	58,021	65,665	Aug 15 04:18 PM
Okupe Oluyemi	Chief Financial Officer	Aug 13 '25	Sale	48.05	11,581	556,420	116,806	Aug 15 04:18 PM
Melissa Baird	Officer	Aug 12 '25	Proposed Sale	47.96	33,333	1,598,651		Aug 12 05:22 PM
Boughton Soleil	Chief Legal Officer	Aug 11 '25	Sale	51.64	2,572	132,818	153,021	Aug 12 04:33 PM
Dudum Andrew	Chief Executive Officer	Aug 07 '25	Sale	50.58	660,000	33,384,120	2,214,769	Aug 11 05:07 PM
Boughton Soleil	Officer	Aug 11 '25	Proposed Sale	51.64	2,572	132,818		Aug 11 10:18 AM
Carroll Patrick Harrison	Chief Medical Officer	Aug 06 '25	Sale	53.58	60,000	3,214,878	169,940	Aug 08 04:19 PM
Carroll Patrick Harrison	Officer	Aug 06 '25	Proposed Sale	53.58	60,000	3,214,881		Aug 06 01:27 PM
Chi Michael	Chief Commercial Officer	Jul 31 '25	Option Exercise	7.09	26,350	186,830	305,004	Aug 04 04:21 PM
Chi Michael	Chief Commercial Officer	Aug 01 '25	Option Exercise	11.53	250	2,882	278,904	Aug 04 04:21 PM
Chi Michael	Chief Commercial Officer	Jul 31 '25	Sale	67.00	26,350	1,765,450	278,654	Aug 04 04:21 PM
Chi Michael	Chief Commercial Officer	Aug 01 '25	Sale	64.44	250	16,110	278,654	Aug 04 04:21 PM
Chi Michael	Officer	Aug 01 '25	Proposed Sale	64.44	250	16,110		Aug 01 11:12 AM
Chi Michael	Officer	Jul 31 '25	Proposed Sale	67.00	26,350	1,765,450		Jul 31 11:02 AM
Boughton Soleil	Chief Legal Officer	Jul 28 '25	Sale	58.70	2,572	150,976	155,593	Jul 29 04:25 PM
Boughton Soleil	Officer	Jul 28 '25	Proposed Sale	58.70	2,572	150,976		Jul 28 12:59 PM
Chi Michael	Chief Commercial Officer	Jul 23 '25	Option Exercise	5.25	13,750	72,146	292,404	Jul 25 05:20 PM
Chi Michael	Chief Commercial Officer	Jul 24 '25	Option Exercise	5.01	2,100	10,521	280,754	Jul 25 05:20 PM
Chi Michael	Chief Commercial Officer	Jul 23 '25	Sale	56.00	13,750	770,000	278,654	Jul 25 05:20 PM
Chi Michael	Chief Commercial Officer	Jul 24 '25	Sale	57.52	2,100	120,792	278,654	Jul 25 05:20 PM
Chi Michael	Officer	Jul 24 '25	Proposed Sale	57.52	2,100	120,792		Jul 24 10:44 AM
Dudum Andrew	Chief Executive Officer	Jul 21 '25	Option Exercise	2.43	125,335	304,564	142,313	Jul 23 04:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HIMS

Hims & Hers Health Inc

Upgrade your FINVIZ experience